m4s0n501

MS Studies

Infinity Clinical Research – Pompano Beach location
Formerly MS Research Associates

572 East McNab Road, Suite 202 • Pompano Beach, Florida 33060
Tel 954-738-1680 • Fax 954-738-1682

Brian Steingo, MD • James Cimera, MD • Jennifer Smrtka, MSCN, ANP-BC

Research Coordinators:
Michele Fistel, LPN, CCRC • Rebecca Radzivill, MS, LMHC, CCRC


CURRENTLY ENROLLING  MULTIPLE SCLEROSIS STUDIES

EPOC: Relapsing-Remitting MS
A 6 month study comparing oral Fingolimod to Rebif, Copaxone, Avonex, Betaseron, or Extavia.

PASS: Relapsing-Remitting MS
An observational study to monitor the long-term safety of oral fingolimod.

DECIDE: Relapsing-Remitting MS
A 3 year study comparing the safety and efficacy of once-monthly subcutaneous Daclizumab to once-weekly intramuscular Avonex.

STRATIFY: Relapsing-Remitting MS

A 2 year study to measure JC virus antibodies in people currently receiving or considering starting Tysabri.

WALKING STUDY: All forms of MS
A 5 week study evaluating 2 doses of twice-daily Dalfampridine versus placebo.

OPERA: Relapsing-Remitting MS
A 2 year study to evaluate the efficacy and safety of intravenous Ocrelizumab given at 5 intervals compared to Rebif 3 times weekly.

ASCEND: Secondary Progressive MS
A 2 year study to assess the efficacy of Tysabri in subjects with Secondary Progressive MS.

We have other exciting new studies starting soon – please contact us for details.